Altimmune, Inc. (ALT)
NASDAQ: ALT · Real-Time Price · USD
4.745
-0.255 (-5.10%)
At close: Apr 1, 2025, 4:00 PM
4.760
+0.015 (0.32%)
After-hours: Apr 1, 2025, 4:48 PM EDT

Altimmune Market Cap

Altimmune has a market cap or net worth of $365.43 million as of April 1, 2025. Its market cap has decreased by -37.66% in one year.

Market Cap
365.43M
Enterprise Value
236.38M
1-Year Change
-37.66%
Ranking
Category
Stock Price
$4.75

Market Cap Chart

Since October 6, 2005, Altimmune's market cap has increased from $81.50M to $365.43M, an increase of 348.38%. That is a compound annual growth rate of 8.00%.

History

DateMarket Cap% Change
Mar 28, 2025409.70M-20.11%
Dec 31, 2024512.80M-15.16%
Dec 29, 2023604.40M-25.26%
Dec 30, 2022808.70M122.17%
Dec 31, 2021364.00M-2.41%
Dec 31, 2020373.00M1,186.21%
Dec 31, 201929.00M61.11%
Dec 31, 201818.00M-42.12%
Dec 29, 201731.10M-85.66%
Dec 30, 2016216.90M77.06%
Dec 31, 2015122.50M6.80%
Dec 31, 2014114.70M17.88%
Dec 31, 201397.30M79.52%
Dec 31, 201254.20M-11.58%
Dec 30, 201161.30M-64.57%
Dec 31, 2010173.00M210.59%
Dec 31, 200955.70M-6.39%
Dec 31, 200859.50M-31.77%
Dec 31, 200787.20M1.04%
Dec 29, 200686.30M4.10%
Dec 30, 200582.90M1.72%
View and export this data all the way back to 2005. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 738.61B
UnitedHealth Group 472.03B
Johnson & Johnson 394.52B
AbbVie 363.15B
Novo Nordisk 305.46B
AstraZeneca 229.16B
Abbott Laboratories 226.88B
Merck & Co. 225.40B
Market Cap Rankings